Free Trial

GE HealthCare Technologies (NASDAQ:GEHC) Given "Hold (C+)" Rating at Weiss Ratings

GE HealthCare Technologies logo with Medical background

Key Points

  • GE HealthCare Technologies' stock has been given a "hold (C+)" rating by Weiss Ratings, with several brokerages also issuing hold or equal weight ratings, indicating mixed sentiment among analysts.
  • The company reported earnings of $1.06 per share, exceeding analysts' estimates and reflecting a year-over-year revenue increase of 3.5% to $5 billion for the quarter.
  • As of now, GE HealthCare Technologies has a consensus rating of "Moderate Buy," with a target price of $85.20, amid active trading with a recent stock price of $72.86.
  • Five stocks we like better than GE HealthCare Technologies.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report)'s stock had its "hold (c+)" rating reiterated by analysts at Weiss Ratings in a research report issued on Tuesday,Weiss Ratings reports.

Several other brokerages have also issued reports on GEHC. Wall Street Zen lowered shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, September 20th. Barclays began coverage on shares of GE HealthCare Technologies in a research report on Monday. They set an "equal weight" rating and a $86.00 price objective for the company. Zacks Research lowered GE HealthCare Technologies from a "strong-buy" rating to a "hold" rating in a report on Monday, September 29th. BTIG Research lifted their price objective on GE HealthCare Technologies from $87.00 to $89.00 and gave the company a "buy" rating in a research report on Monday. Finally, Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a research report on Thursday, September 18th. Six research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of "Moderate Buy" and a consensus target price of $85.20.

Get Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded up $1.02 during trading hours on Tuesday, reaching $72.86. The company had a trading volume of 1,033,701 shares, compared to its average volume of 3,885,586. The business has a fifty day moving average price of $74.33 and a 200-day moving average price of $72.16. GE HealthCare Technologies has a one year low of $57.65 and a one year high of $94.80. The firm has a market cap of $33.26 billion, a PE ratio of 14.92, a price-to-earnings-growth ratio of 2.71 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the previous year, the business posted $1.00 earnings per share. The business's revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its holdings in shares of GE HealthCare Technologies by 52.7% during the 1st quarter. Farther Finance Advisors LLC now owns 4,493 shares of the company's stock worth $357,000 after acquiring an additional 1,550 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of GE HealthCare Technologies by 19.2% during the 1st quarter. GAMMA Investing LLC now owns 9,559 shares of the company's stock worth $772,000 after acquiring an additional 1,543 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of GE HealthCare Technologies by 2.4% during the 1st quarter. Assenagon Asset Management S.A. now owns 12,891 shares of the company's stock worth $1,040,000 after acquiring an additional 300 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in GE HealthCare Technologies by 23.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 50,859 shares of the company's stock valued at $4,105,000 after buying an additional 9,769 shares during the period. Finally, Janney Montgomery Scott LLC raised its holdings in GE HealthCare Technologies by 6.0% during the 1st quarter. Janney Montgomery Scott LLC now owns 57,775 shares of the company's stock valued at $4,663,000 after buying an additional 3,246 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

About GE HealthCare Technologies

(Get Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Featured Stories

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in GE HealthCare Technologies Right Now?

Before you consider GE HealthCare Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.

While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.